Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type

Overview of attention for article published in Cancer Epidemiology, Biomarkers & Prevention, December 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 2 news outlets
patent: 30 patents

facebook: 1 Facebook page

Readers on

mendeley: 432 Mendeley

So far, Altmetric has seen 2 news stories from 2 outlets.

Caris Life Sciences Study Shows Molecular Profiling May Expand Use of PD-1 and PD-L1 Inhibitors to Wide Variety of Cancers

Bio-Medicine.org, 12 Nov 2014

IRVING, Texas , Nov. 12, 2014 /- Caris Life Sciences, a biosciences company focused on fulfilling the promise of precision…

Caris Life Sciences Study Shows Molecular Profiling May Expand Use of PD1 and PDL1 Inhibitors to Wide Variety of Cancers

Bioportfolio, 12 Nov 2014

IRVING Texas Nov. 12 2014 PRNewswire Caris Life Sciences a biosciences company focused on fulfilling the promise of precision…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.